Upload
vinay-shiva-prasad
View
17
Download
3
Embed Size (px)
Citation preview
IQ4I Research & Consultancy Pvt. Ltd. Page 1
Implantable Biomaterials Global Market
–Forecast to 2022
Implantable Biomaterials Global Market estimated to be worth $21,124.2 million by 2022 IQ4I Research & Consultancy published a new report on “Implantable Biomaterials
Global Market – Forecast To 2022” This report analyzes and studies the overall market,
major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific
and Rest of the World
IQ4I’s Report Contains 220 market data tables and 81 figures spread through 497
pages and an exhaustive TOC on “Implantable Biomaterials Global Market [Type (Metal and Metal alloys (Titanium & its Alloys, Cobalt-Chrome, Stainless Steel, Magnesium & Alloys and others), Synthetic Polymers (Polyetheretherketone (PEEK), Polytetrafluoroethylene (PTFE), Polyethylene terephthalate (PETE), Polyethylene / Ultra High Molecular Weight Polyethylene (UHMWPE), Polymethylmethacrylate (PMMA), Polyurethanes, Silicone, Resorbable polymers, Hydrogels and others); Ceramic Biomaterials (Calcium compositions, Aluminium oxide, Zirconia, Carbon, Glass and Silicon nitride); Natural biomaterials (Cellulose, Collagen & Gelatin, Hyaluronic Acid / Hyaluronan, Fibrin, Chitin / Chitosan, Elastin, Silk, and Others) and Composites; APPLICATIONS (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications.); REGION (North America (United States and Others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Latin America, Middle East and Others)]
This report analyzes the Implantable Biomaterials global market in terms of market revenue
($ million) for all segments and it enables Implantable Biomaterials global market
stakeholders such as device manufacturers, distributors and wholesalers, OEM (Original
Equipment Manufacturers)/contract manufacturers, hospitals and various academic research
institutes to identify and analyze market expansion opportunities, upcoming technologies
and competition in Implantable Biomaterials global market.
A biomaterial is a substance intended to interface with biological systems to evaluate, treat,
augment, or replace any tissue, organ, or function of the body for a life time, such as total hip
replacements, as well as those that interact with the body for short periods of time, such as
soft contact lenses. The source of biomaterials can be derived from natural or synthetic by
variety of processes laboratory using metallic, ceramic, polymer, natural and composite raw
materials. The selection of biomaterial is dependent on the application and properties of
materials. Biomaterials are used to develop and manufacture implantable medical devices
and grafts in many medical conditions. As estimated by IQ4I Research, implantable
IQ4I Research & Consultancy Pvt. Ltd. Page 2
Implantable Biomaterials Global Market
–Forecast to 2022
biomaterials global market is expected to grow at a strong CAGR to reach $21,124.2 million
by 2022.
The increasing aging population, increasing demand for minimally invasive procedures,
increasing research and development investments, growing demand for plastic surgery,
miniaturization of implant devices, advance technologies and reimbursements are the factors
driving the biomaterials global market. However, limitations of biomaterial based products,
stringent regulations posed on biomaterial based products, complications due to implant
rejection, cytotoxicity, and corrosion of biomaterials implant are restraining the growth of
biomaterials global market.
Advancements and newer technologies like 3D printing are revolutionizing implantable
biomaterials market. 3D Printing promises to produce complex biomedical devices using
computer design based on patient-specific anatomical data. Before 3D Printing can be used
routinely for the regeneration of complex tissues (e.g. bone, cartilage, muscles, vessels,
nerves in the craniomaxillofacial complex), and complex organs with intricate 3D
microarchitecture (e.g. liver, lymphoid organs). The commonly used 3D printing technologies
are Fused Deposition Modeling, Selective Laser Sintering, Stereolithography, and 3D
Plotting/Direct-Write/ Bioprinting. With the increase in 3D printing technology better and
anatomically accurate implants can be manufactured which directly affects the consumption
of biomaterials by medical implants manufacturing companies.
A leading advanced materials and 3D printing company, Oxford Performance Materials,
Inc. (OPM), has announced that it has received 510(k) clearance from the US Food & Drug
Administration (FDA) for its 3D printed OsteoFab Patient-Specific Facial Device. Currently, it
is the only cleared 3D printed polymeric implant for facial indications of its kind, although it is
not completely new territory for OPM as the company previously got FDA clearance for
another kind of 3D printed medical implant in February 2013.
Amedica Corporation is the first company to create medical silicon nitride ceramics using a
3D printing process called robotic deposition, or robocasting. The 3D printed products have
been shown to possess similar properties to traditionally manufactured alternatives.
In February 2016 BioArchitects received 510(k) clearance by the U.S. Food and Drug
Administration – FDA, for the company’s 3D printed patient specific titanium
cranial/craniofacial plate implant. Designed for the repair of defects in the non-loadbearing
IQ4I Research & Consultancy Pvt. Ltd. Page 3
Implantable Biomaterials Global Market
–Forecast to 2022
bones of the head and face, each custom designed plate is permanently attached to the
skull and/or face with self-tapping titanium screws.
The implantable biomaterials global market is segmented based on type, application, and
geography. The market by type is divided into Metallic biomaterials, Synthetic polymers,
Ceramic biomaterials, Natural biomaterials and Composite biomaterials. The implantable
biomaterials application is further sub-segmented into Cardiovascular, Orthopedic, Dental,
Plastic Surgery, Wound Healing, Ophthalmology, Neurology and Other Applications. The
Orthopedic occupied highest market in implantable biomaterials application market.
Geographically, North American regions held the largest market share and U.S. dominates
the North American region with market share of 79.2% and expected to show a CAGR due
to the high advanced healthcare facilities, increasing ageing population, increased growing
awareness about the technological advancements, availability of Medicare and third party
insurance facilities, easy availability of skilled personnel are driving the market growth. In
Asia-Pacific region Japan dominates the biomaterials market with share of 30.7% and
expected to grow at a strong CAGR due to high levels of healthcare expenditure and a
massive elderly population, technological advancements and reimbursement by Japan’s
National Health Insurance (NHI) system are the major factors contributing the biomaterials
market in Japan. Japan has world’s largest and fastest rates of aging population in the world
which results in high rates of orthopedic, dental, ophthalmology and cardiovascular
disorders. In Rest of the World regions Latin America countries especially Brazil dominates
the implantable biomaterials market with share of 50.7% and is expected to grow at the
strong rate due to The growth in this market is mainly due to the high acceptance of
technological advancements, Medicare facilities, sophisticated infrastructure related to
healthcare and high expenditure and mainly the easy availability of skilled personnel and
treatment style has led the Brazil as the dominant region of biomaterials market.
Some of the prominent players in implantable biomaterials market include Solvay Advanced
Polymers, LLC (Belgium), Evonik Industries AG (Germany), Carpenter Technology
Corporation (U.S.), Royal DSM (Netherlands), Johnson Matthey Plc (U.K.), Morgan
Advanced Materials plc (U.K.), Materion (U.S.), Victrex PLC (Invibio Biomaterial Solutions )
(U.K.) and Collagen solutions (U.K.), Corbion N.V. (Netherlands), Landec Corporation (U.S.).
Reasons for buying this report:
IQ4I Research & Consultancy Pvt. Ltd. Page 4
Implantable Biomaterials Global Market
–Forecast to 2022
Analysis of the implantable biomaterials global market by identifying various
segments by type, source, application, and geography.
Revenue forecast of the implantable biomaterials market and strategic analysis of
each submarket with respect to segmental growth trends.
Analysis of the major market trends and factors driving or inhibiting the growth of the
implantable biomaterials global market.
Revenue forecast of the healthcare analytics market with respect to North America,
Europe, Asia-Pacific and the Rest of the World (RoW) regions.
Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
Regional market share analysis of implantable biomaterials by major players.
Market share analysis of key players in implantable biomaterials, details of their
product offerings, revenues, business strategies and SWOTs.
Established and Emerging players (86 companies) and their product offerings.
IQ4I Research & Consultancy Pvt. Ltd. Page 5
Implantable Biomaterials Global Market
–Forecast to 2022
FIGURE 1
IMPLANTABLE BIOMATERIALS GLOBAL MARKET SEGMENTATION
Implantable Biomaterials Global Market
Metallic
Biomaterials
By Application By Region
Synthetic
Polymers Cardiovascular NA
U.S.
Others
EU
Germany, France,
U.K., Others
By Type
Orthopedic
Dental
Plastic surgery
Wound healing
Ophthalmology
Neurology
Others
Ceramic
Biomaterials
Natural
BiomaterialsComposites
APAC
Japan, China,
India, Others
RoW
Latin America,
Middle East, Others
Titanium &
alloys
Stainless
Steel
Magnesium
& alloys
Others
Cobalt-
Chrome
PEEK
PETE
UHMWPE
PMMA
Hydrogel
Resorbable
Polymers
Silicone
PTFE
PU
Others
Carbon
Zirconia
Aluminium
oxide
Calcium
composition
Glass
Silicon
nitride
Cellulose
Hyaluronan
Fibrin
Chitin
Others
Silk
Collagen
Elastin